In the Greater Mekong subregion (GMS), artemisinin resistance is increasingly compounded
by partner drug resistance, causing high failure rates of artemisinin combination therapies in …

Artemisinin-based combinations are currently the most effective anti-malarials and, in
addition to vector control, have led to significant declines in malaria morbidity and mortality …

Background: Artemisinin and partner drug-resistant falciparum malaria is expanding over
the Greater Mekong Sub-region (GMS). Eliminating falciparum malaria in the GMS while …

Based on the emergence and spread throughout the Greater Mekong Subregion (GMS) of
multiple artemisinin-resistant lineages, the prevalence of multidrug resistance leading to …

The goal of the GPARC is to protect ACTs for treatment of P. falciparum malaria. The GPARC
comes at a critical juncture. Artemisinin resistance has been confirmed in a limited area …

Malaria remains a global health challenge, disproportionately affecting vulnerable
communities. Despite substantial progress, the emergence of anti-malarial drug resistance …

Despite significant improvement in the malaria situation of the Greater Mekong Subregion
(GMS), malaria control for the region continues to face a multitude of challenges. The …

Malaria is a significant public health problem and impediment to socioeconomic
development in countries of the Greater Mekong Subregion (GMS), which comprises …

Recent gains in the fight against malaria are threatened by the emergence and spread of
artemisinin and partner drug resistance in Plasmodium falciparum in the Greater Mekong …

Background Evidence suggests that the PfKelch13 mutations that confer artemisinin
resistance in falciparum malaria have multiple independent origins across the Greater …